BioHealth News Archive
NEA Scores Two IPOs in a Week – peHub
It’s tough to move the needle on a multi-billion-dollar venture fund. That’s one reason New Enterprise Associates, which has managed mega-funds about as long…
Read More
QIAGEN and China’s BioBAY open translational medicine center to accelerate creation of novel companion diagnostics
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and SIP Biotech Development Co., Ltd. (BioBAY) today announced the opening of QIAGEN (Suzhou) Translational Medicine…
Read More
NHLBI Funding and Research Opportunity Announcements – May
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest: NIH Guide Notice:…
Read More
In-vivo Methods for Assessing Placental Development and Function (SBIR)
Purpose The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes invite grant applications for research on the development…
Read More
BARDA Partners with GSK for Hospital and Biothreat Antibacterials | Global Biodefense
The U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has entered into a collaborative agreement with Glaxo Smith Kline…
Read More
Success In mHealth: Shifting Focus From The ‘m’ To The ‘Health’ – Forbes
Poor maternal, infant, and child health as well as inadequate coverage of family planning remain significant global health problems facing low- and middle-income countries…
Read More
AstraZeneca picks BioMed Campus for HQ – Business Weekly
Medical technology pioneer AstraZeneca has chosen the Cambridge Biomedical Campus at the Addenbrooke’s Hospital site in Cambridge UK for its new global headquarters. It…
Read More
Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Awards Celebration
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association with more than 400 biotechnology and technology members employing more than 200,000 in…
Read More
1st Annual Pediatric Surgical Innovation Symposium
June 13th - The Ritz-Carlton, Washington, DC There is a critical unmet need in the U.S. and around the world for the development of…
Read More
UMB Students in Six Schools Team Up To Find New HIV Infections, Aim Patients to Care
In a unique program called Preparing the Future (PTF), 334 students have completed classroom and hands-on training to equip them to address the HIV…
Read More
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics | 2013 | Press releases | Media | GlaxoSmithKline
GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), have…
Read More
Entrepreneur Of The Year® Awards Ceremony – Ernst & Young LLP
Our world needs entrepreneurs Their ability to innovate, to inspire others, to power a business along the difficult journey from start-up to market leader…
Read More
Should I Join an Accelerator? – Business Insider
Today is Demo Day for Techstars Boston. I love Techstars Demo Days for many reasons, not the least of which is the amazing community…
Read More
Debunking Myths About Biotech Venture Capital – Forbes
There are lots of myths about venture capital and biotech in particular, as noted previously on this blog. Many of these myths are deeply…
Read More
Glaxo to Get Up to $200 Million From U.S. for Biothreat Research – Businessweek
GlaxoSmithKline Plc (GSK), the U.K.’s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an…
Read More